Evidence map›Paper›PMID 33720993›Full record

ArticlePLoS pathogens2021

Two novel loci underlie natural differences in Caenorhabditis elegans abamectin responses.

Kathryn S Evans, Janneke Wit, Lewis Stevens, Steffen R Hahnel, Briana Rodriguez, Grace Park, Mostafa Zamanian, Shannon C Brady, Ellen Chao, Katherine Introcaso and 2 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Article
  3. Natural variation suggests candidate genes underlying Caenorhabditis elegans susceptibility to diverse toxicants.Toxicological sciences : an official journal of the Society of Toxicology · 2026
    Article
  4. Natural variation suggests candidate genes underlyingbioRxiv : the preprint server for biology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kathryn S EvansMolecular Biosciences, Northwestern University, Evanston, Illinois, United States of America.ORCID 0000-0002-1388-8155
Janneke WitMolecular Biosciences, Northwestern University, Evanston, Illinois, United States of America.ORCID 0000-0002-3116-744X
Lewis StevensMolecular Biosciences, Northwestern University, Evanston, Illinois, United States of America.ORCID 0000-0002-6075-8273
Steffen R HahnelMolecular Biosciences, Northwestern University, Evanston, Illinois, United States of America.
Briana RodriguezMolecular Biosciences, Northwestern University, Evanston, Illinois, United States of America.ORCID 0000-0002-5282-0815
Grace ParkMolecular Biosciences, Northwestern University, Evanston, Illinois, United States of America.ORCID 0000-0002-7158-1637
Mostafa ZamanianMolecular Biosciences, Northwestern University, Evanston, Illinois, United States of America.ORCID 0000-0001-9233-1760
Shannon C BradyMolecular Biosciences, Northwestern University, Evanston, Illinois, United States of America.
Ellen ChaoMolecular Biosciences, Northwestern University, Evanston, Illinois, United States of America.ORCID 0000-0002-6938-0211
Katherine IntrocasoMolecular Biosciences, Northwestern University, Evanston, Illinois, United States of America.ORCID 0000-0002-7253-8390
Robyn E TannyMolecular Biosciences, Northwestern University, Evanston, Illinois, United States of America.ORCID 0000-0002-0611-3909
Erik C AndersenMolecular Biosciences, Northwestern University, Evanston, Illinois, United States of America.ORCID 0000-0003-0229-9651

Funding

CELLULAR &MOLECULAR BASIS OF DISEASE TRAINING PROGRAMT32GM008061 · NIGMS · NORTHWESTERN UNIVERSITY · PI CARTHEW, RICHARD W. · 1985 to 2022
$17.1M
Discovery of Novel Benzimidazole Resistance MechanismsR01AI153088 · NIAID · NORTHWESTERN UNIVERSITY · PI Erik Christian Andersen, James Solomon Fraser · 2020 to 2026
$4.3M
Discovery and validation of avermectin resistance loci in free-living and parasitic nematodesR21AI121836 · NIAID · NORTHWESTERN UNIVERSITY · PI ANDERSEN, ERIK CHRISTIAN · 2016 to 2017
$424k
NIAID NIH HHS R01 AI153088NIAID NIH HHS R21 AI121836NIGMS NIH HHS T32 GM008061
6 · The paper itself

Abstract

Parasitic nematodes cause a massive worldwide burden on human health along with a loss of livestock and agriculture productivity. Anthelmintics have been widely successful in treating parasitic nematodes. However, resistance is increasing, and little is known about the molecular and genetic causes of resistance for most of these drugs. The free-living roundworm Caenorhabditis elegans provides a tractable model to identify genes that underlie resistance. Unlike parasitic nematodes, C. elegans is easy to maintain in the laboratory, has a complete and well annotated genome, and has many genetic tools. Using a combination of wild isolates and a panel of recombinant inbred lines constructed from crosses of two genetically and phenotypically divergent strains, we identified three genomic regions on chromosome V that underlie natural differences in response to the macrocyclic lactone (ML) abamectin. One locus was identified previously and encodes an alpha subunit of a glutamate-gated chloride channel (glc-1). Here, we validate and narrow two novel loci using near-isogenic lines. Additionally, we generate a list of prioritized candidate genes identified in C. elegans and in the parasite Haemonchus contortus by comparison of ML resistance loci. These genes could represent previously unidentified resistance genes shared across nematode species and should be evaluated in the future. Our work highlights the advantages of using C. elegans as a model to better understand ML resistance in parasitic nematodes.

Indexed as

AnimalsAnthelminticsCaenorhabditis elegansChloride ChannelsDrug ResistanceHaemonchusIvermectinNematode InfectionsabamectinAnthelminticsChloride Channelsglutamate-gated chloride channelsIvermectin

Identifiers

PMID33720993
PMCPMC7993787

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.